
Tolebrutinib Delays Disability Progression For Secondary Progressive Multiple Sclerosis
Tolebrutinib delayed disability progression for patients with non-relapsing secondary progressive multiple sclerosis (nrSPMS) in the HERCULES (NCT04411641) phase 3 study. The data were published in The New England Journal of Medicine and presented at the …